Impact Biotech vs Upstream Bio
Impact Biotech vs Upstream Bio, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Impact Biotech is on 39/100 and Upstream Bio on 61/100.
Where each one leads
Impact Biotech
Leads on none of the measures we hold for both companies.
Upstream Bio
- our overall score: 61/100 against 39/100
- agent readiness: 39/100 against 21/100
- domain rating: 32/100 against 20/100
- headcount: 75 against 42
- headcount growth: +43.4% against +16.9%
- funding raised: $400M against $2.7M
- LinkedIn following: 11,799 against 1,470
At a glance
| Measure | Impact Biotech | Upstream Bio |
|---|---|---|
| What it is | Develops and launches Padeliporfin VTP therapy for solid tumor treatment. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Cancer, Therapeutics, Biotech | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 1996 | 2021 |
| Headquarters | Tel Aviv, Israel | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Impact Biotech | Upstream Bio |
|---|---|---|
| Employees | 42 | 75 |
| Headcount growthLast 12 months | +16.9% | +43.4% |
| Total funding | $2.7M | $400M |
| Latest round | Grant | Series B |
| LinkedIn followers | 1,470 | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Impact Biotech | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 61/100 |
| Traction | 49/100 | 59/100 |
| Team | Not published | 70/100 |
| Search visibility | 34/100 | 37/100 |
| Quality | 45/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Impact Biotech | Upstream Bio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
Impact Biotech vs Upstream Bio: common questions
Which is better, Impact Biotech or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Impact Biotech and Upstream Bio compare on the numbers?
Upstream Bio leads on our overall score (61/100 against 39/100), agent readiness (39/100 against 21/100), domain rating (32/100 against 20/100), headcount (75 against 42), headcount growth (+43.4% against +16.9%), funding raised ($400M against $2.7M), LinkedIn following (11,799 against 1,470).
Read the full Impact Biotech review and pricing or the Upstream Bio review and pricing. You can also browse other Impact Biotech alternatives we track.